PreprintCold Spring Harb Perspect Med2018
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer.
- Journal
- Cold Spring Harb Perspect Med
- Published
- 4 September 2018
- Citations
- 742
- Type
- Preprint
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 2
Grants 5
- Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma P01CA203657↗
- Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy P50CA196510↗
- Biological Activity of Ras Oncogenes R01CA042978↗
- Mechanisms of PAK1 activation, signaling and tumor resistance R01CA175747↗
- Identification of synthetic lethal interactors in pancreatic cancer U01CA199235↗